REcanalization of Distal Cerebral Vessels in Acute Stroke Using ApeRio®
Sponsor: Acandis GmbH
Listed as NCT04479020, this observational or N/A phase trial focuses on Acute Stroke and remains completed. Sponsored by Acandis GmbH, it has been updated 9 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Jan 2025 — Sep 2025 [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Sep 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Sep 2022 — Sep 2023 [monthly]
Recruiting
-
Sep 2021 — Sep 2022 [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting
First recorded
Jul 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Acandis GmbH
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Berlin, Germany , Bonn, Germany , Cologne, Germany , Düsseldorf, Germany , Fulda, Germany , Göttingen, Germany , Homburg, Germany , Magdeburg, Germany , Minden, Germany , München, Germany and 1 more location